Feedback

Corneal protective effects of a new ophthalmic formulation based on vitamin B12 and sodium hyaluronate

Affiliation
Department of Biomedical and Biotechnological Sciences ,School of Medicine ,University of Catania ,Catania ,Italy
Lazzara, Francesca;
Affiliation
Department of Biomedical and Biotechnological Sciences ,School of Medicine ,University of Catania ,Catania ,Italy
Conti, Federica;
Affiliation
Department of Biomedical and Biotechnological Sciences ,School of Medicine ,University of Catania ,Catania ,Italy
Maugeri, Grazia;
Affiliation
Department of Biomedical and Biotechnological Sciences ,School of Medicine ,University of Catania ,Catania ,Italy
D’Agata, Velia;
Affiliation
Department of Biomedical and Biotechnological Sciences ,School of Medicine ,University of Catania ,Catania ,Italy
Sotera, Ludovica;
Affiliation
Department of Biomedical and Biotechnological Sciences ,School of Medicine ,University of Catania ,Catania ,Italy
Bucolo, Claudio

Introduction Corneal damage can happen due to a variety of insults, including environmental factors and iatrogenic issues. For instance, the corneal epithelium is sensitive to oxidative stress caused by reactive oxygen species (ROS) or by ultraviolet B (UVB) radiation. Moreover, the strictly correlated oxidative damage and inflammatory processes impair the corneal reparative wound healing mechanism. Corneal protection after damage remains an unmet medical need that requires urgent management. Sodium hyaluronate is known to protect the cornea against oxidative and inflammatory injury. Additionally, vitamin B12 is a good candidate for counteracting corneal damage, helping preserve visual functions. Methods The present study aimed to investigate the potential protective effect of an ophthalmic formulation based on 0.01% vitamin B12% and 0.15% sodium hyaluronate (DROPYAL EVO) compared to other ophthalmic formulations containing sodium hyaluronate and trehalose (TRIMIX and THEALOZ DUO). Two different in vitro models of corneal damage were carried out in corneal epithelial cells exposed to hydrogen peroxide (H 2 O 2 , 1 mM) or UVB (20 mJ/cm 2 ). Cell viability, cytotoxicity, ROS production, and mRNA expression of pro-inflammatory cytokines (TNF-α and IL-1β) were assessed by MTT, LDH, 2′,7′–dichlorofluorescein diacetate (DCFDA) assays and Real-time PCR, respectively. Additionally, the ability of ophthalmic formulations to affect the wound healing process in corneal epithelial cells was assessed at different time points by scratch wound healing assay. Results The eye drops containing vitamin B12 were able to significantly counteract oxidative and inflammatory damage in corneal epithelial cells exposed to H 2 O 2 stimulus and UVB radiation, in terms of ROS production and pro-inflammatory cytokines expression. Additionally, the eye drops containing vitamin B12 obtained significantly better outcomes in terms of wound closure at 36 h and 48 h after scratching the corneal epithelial cells, compared to the other two formulations containing trehalose. Discussion Vitamin B12 potentially enhances the protective effect of sodium hyaluronate, accelerating the wound healing process and modulating oxidative stress and inflammation. Vitamin B12, in combination with sodium hyaluronate, could represent a promising approach to managing corneal epithelial damage. Further clinical investigations are needed to confirm this data.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2025 Lazzara, Conti, Maugeri, D’Agata, Sotera and Bucolo.

Use and reproduction: